End-of-day quote
Other stock markets
|
||
- EUR | - |
Jul. 01 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
May. 22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
Chart calendar Active Biotech AB
Upcoming events on Active Biotech AB
Past events on Active Biotech AB
2024-05-29 | Redeye Growth Day |
2024-05-21 | Annual General Meeting |
2024-05-08 12:00 pm | Q1 2024 Earnings Release |
2024-02-08 02:30 am | Q4 2023 Earnings Release |
2023-11-23 12:00 am | Redeye Life Science Day |
2023-11-14 | Rights Issue: 3 new shares @ 0.45 SEK for 7 existing shares |
2023-11-09 02:30 am | Q3 2023 Earnings Release |
2023-08-24 02:30 am | Q2 2023 Earnings Release |
2023-06-05 08:00 am | American Society of Clinical Oncology Conference - Abstract No - 8042 |
2023-06-01 12:00 am | Redeye Growth Day |
2023-05-24 11:00 am | Annual General Meeting |
2023-05-04 02:30 am | Q1 2023 Earnings Release |
2023-02-08 | Q4 2022 Earnings Release |
2023-01-19 12:00 am | Redeye Fight Cancer Seminar |
2022-11-02 | Q3 2022 Earnings Release |
2022-08-16 | Rights Issue: 1 new share @ 1 SEK for 4 existing shares |
2022-08-04 02:15 am | Interim 2022 Earnings Release |
2022-05-18 | Annual General Meeting |
2022-04-21 02:30 am | Q1 2022 Earnings Release |
2022-02-09 04:30 pm | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 | 6,70 7,00 -4.29% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million SEK | Released Forecast Spread | 0,00 | -31,0 -30,0 -3.33% | -48,5 -46,0 -5.43% | -56,4 -55,0 -2.55% | -44,8 -41,0 -9.27% | -43,0 |
EBIT Million SEK | Released Forecast Spread | 0,00 | -32,3 -31,0 -4.19% | -49,8 -46,0 -8.26% | -57,9 -55,0 -5.27% | -46,5 -41,0 -13.41% | -43,0 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 | -32,2 -31,0 -3.87% | -49,8 -46,0 -8.26% | 0,00 0,00 - | -45,8 -40,0 -14.5% | -42,8 |
Net income Million SEK | Released Forecast Spread | -34,1 | -32,2 -31,0 -3.87% | -49,8 -46,0 -8.26% | -58,4 -56,0 -4.29% | -45,8 -40,0 -14.5% | -42,8 |
EPS SEK | Released Forecast Spread | -0,24 | -0,22 -0,21 -4.76% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 06/02/20 | 11/02/21 | 25/03/22 | 09/02/23 | 08/02/24 | - |
Past sector events for Active Biotech AB
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- ACTI Stock
- BTPC Stock
- Calendar Active Biotech AB